ls6003 haemotology lecture 1 Flashcards
what is conventional chemotherapy
cytotoxic to most cells, meaning it can damage normal, healthy cells in addition to damaging and killing cancer cells.
what is targeted therapy
Targeted drugs often work by blocking cancer cells from copying themselves. This means they can help stop a cancer cell from dividing and making new cancer cells.
whats palliative treatment
prolongs survival, improves QoL, unlikely to cure
In leukaemia what is the next option after a patient fails cycles of chemo in response to diagnosis with leukaemia
bone marrow transplant
what is salvage chemotherapy
potentially curative combination chemo, given to patients who hav efailed or recurred after curative
what is adjuvant chemo
Adjuvant therapies are delivered after the primary treatment, to destroy remaining cancer cells.
what is neo-adjuvant
Neoadjuvant therapies are delivered before the main treatment, to help reduce the size of a tumor or kill cancer cells that have spread.
what factors are considered when designin gcombination therapy
-drugs with known efficacy against a particular tumour type
-non-overlapping toxicity profile
-possible synergistic killing effects
-action at different phases in cell cycle
define leukaemia
malignant clonal disorder of immature cells in haemopoietic system derived from a single ancestral transformed cell with genetic alteration
what is AML
acute myeloid leukaemia
can you have genetic predispostion to AML
chromosomal instability syndromes e.g. bloom syndrome (quite rare)
symptoms of AML
anaemia
neutropenia
thrombocytopenia (petechiae)
organomeglay
gum hypertrophy
whats the pathogenesis of AML
escape from apoptosis, loss of cell cycle control, genomic instability
activation of RTK->PI3K signalling ->AKT and mTOR
BCL2 over-expression = anti-apoptosis protein
TP53 mutations (stops cell cycle)
what is induction
high-dose combination therpay with intent to inudce complete remission (50->5% bone marrow leukaemia cell))
whats consolidation
aims to remove any residual leukaemia cells after induction